Redwood City, CA, United States of America

Relypsa, Inc.


USPTO Granted Patents = 32

% Expired Patents = 31.3



Trademarks = 1

Forward Citations = 195

Loading Chart...
Loading Chart...

38 inventors (with patents filed for the assignee):

goldMedal Dominique Charmot (21 out of 113 patents)

silverMedal Mingjun Liu (21 out of 33 patents)

bronzeMedal Gerrit Klaerner (18 out of 50 patents)

4 Eric F Connor (17 out of 45 patents)

5 Han-Ting Chang (12 out of 32 patents)

6 Michael James Cope (10 out of 26 patents)

7 Futian Liu (9 out of 33 patents)

8 Jerry M Buysse (8 out of 28 patents)

9 Han Ting Chang (8 out of 30 patents)

10 Paul Mansky (7 out of 54 patents)

11 Kalpesh N Biyani (6 out of 24 patents)

12 Jun Shao (6 out of 13 patents)

13 YongQi Mu (6 out of 95 patents)

14 John Fordtran (6 out of 9 patents)

15 Faleh Salaymeh (5 out of 6 patents)


32 patents:

Relypsa, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of non-systemic polymeric drugs for the treatment of renal, cardiovascular, and metabolic diseases.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Relypsa, Inc.
32 Patents

#64 in Redwood City, CA

#2,527 in California

#10,575 in US

#20,620 in the World

Redwood City, CA (US)
Redwood City, CA, United States of America
Forward Citations = 195

38 inventors:

Please report any incorrect information to [email protected]
Loading…